Inventor · disambiguated record
Qun Zhou
Also filed as: ZHOU QUN · ZHOU QUN Y · ZHOU QUN-YONG
28 granted patents·18 pending applications·233 citations·filing 1992–2024
96Inventor score
Top patents by PatentIndex Score
46 records- 0196US11130816B2Site-specific antibody-drug conjugation through glycoengineeringGENZYME CORP·Filed 2019·Granted Sep 28, 2021·6 cites·20 claims
- 0295US12110338B2Site-specific antibody-drug conjugation through glycoengineeringGENZYME CORP·Filed 2021·Granted Oct 8, 2024·2 cites·29 claims
- 0395US10995148B2Site-specific glycoengineering of targeting moietiesGENZYME CORP·Filed 2015·Granted May 4, 2021·8 cites·39 claims
- 0494US9580511B2Site-specific antibody-drug conjugation through glycoengineeringGENZYME CORP·Filed 2014·Granted Feb 28, 2017·17 cites·47 claims
- 0593US11160874B2Glycoengineered antibody drug conjugatesGENZYME CORP·Filed 2018·Granted Nov 2, 2021·6 cites·15 claims
- 0693US10214589B2Site-specific antibody-drug conjugation through glycoengineeringGENZYME CORP·Filed 2017·Granted Feb 26, 2019·9 cites·18 claims
- 0793US10064952B2Glycoengineered antibody drug conjugatesGENZYME CORP·Filed 2015·Granted Sep 4, 2018·8 cites·21 claims
- 0893US7700321B2Antibody-based therapeutics with enhanced ADCC activityGENZYME CORP·Filed 2006·Granted Apr 20, 2010·42 cites·10 claims
- 0992US11279725B2Oligosaccharide-protein conjugatesGENZYME CORP·Filed 2019·Granted Mar 22, 2022·6 cites·19 claims
- 1090US2025066497A1Site-specific antibody-drug conjugation through glycoengineeringGENZYME CORP·Filed 2024·Application pending·0 cites
- 1188US11697690B2Site-specific glycoengineering of targeting moietiesGENZYME CORP·Filed 2021·Granted Jul 11, 2023·1 cites·20 claims
- 1287US10464962B2Oligosaccharide-protein conjugatesGENZYME CORP·Filed 2016·Granted Nov 5, 2019·5 cites·6 claims
- 1387US7259240B2Primate prokineticin receptor polypeptidesUNIV CALIFORNIA·Filed 2004·Granted Aug 21, 2007·13 cites·2 claims
- 1486US8835614B2Oligosaccharide-protein conjugatesAVILA LUIS Z·Filed 2009·Granted Sep 16, 2014·10 cites·15 claims
- 1586US7052674B2Prokineticin polypeptides, related compositions and methodsUNIV CALIFORNIA·Filed 2002·Granted May 30, 2006·32 cites·3 claims
- 1684US9493498B2Oligosaccharide-protein conjugatesGENZYME CORP·Filed 2014·Granted Nov 15, 2016·6 cites·14 claims
- 1782US8071336B2Antibody-based therapeutics with enhanced ADCC activityMCPHERSON JOHN M·Filed 2010·Granted Dec 6, 2011·11 cites·12 claims
- 1881US2024059793A1Site-specific glycoengineering of targeting moietiesGENZYME CORP·Filed 2023·Application pending·0 cites
- 1981US2024117071A1Site-specific glycoengineering of targeting moietiesGENZYME CORP·Filed 2023·Application pending·0 cites
- 2079US12252504B2Oligosaccharide-protein conjugatesGENZYME CORP·Filed 2022·Granted Mar 18, 2025·0 cites·5 claims
- 2176US8101158B1Methods for treating cerebrovascular disease comprising administering an agent that inhibits prokineticin receptor activityZHOU QUN-YONG·Filed 2008·Granted Jan 24, 2012·2 cites·6 claims
- 2276US2024218051A1Modified binding polypeptides for optimized drug conjugationGENZYME CORP·Filed 2023·Application pending·0 cites
- 2375US2025206824A1GLYCOENGINEERED Fc VARIANT POLYPEPTIDES WITH ENHANCED EFFECTOR FUNCTIONABLYNX NV·Filed 2024·Application pending·0 cites
- 2473US2023391849A1Modified binding polypeptides for optimized drug conjugationGENZYME CORP·Filed 2023·Application pending·0 cites
- 2572US2024166750A1GLYCOENGINEERED Fc VARIANT POLYPEPTIDES WITH ENHANCED EFFECTOR FUNCTIONABLYNX NV·Filed 2023·Application pending·0 cites
- 2671US8722896B2Prokineticin receptor antagonists and uses thereofZHOU QUN-YONG·Filed 2009·Granted May 13, 2014·2 cites·12 claims
- 2771US7115560B2Methods for modulating gastric secretion using prokineticin receptor antagonistsUNIV CALIFORNIA·Filed 2004·Granted Oct 3, 2006·4 cites·39 claims
- 2870US2022088214A1Glycoengineered antibody drug conjugatesGENZYME CORP·Filed 2021·Application pending·0 cites
- 2968US11879004B2Modified binding polypeptides for optimized drug conjugationGENZYME CORP·Filed 2021·Granted Jan 23, 2024·0 cites·26 claims
- 3067US2025154262A1Fc DOMAIN VARIANTS WITH ENHANCED Fc RECEPTOR BINDINGABLYNX NV·Filed 2024·Application pending·0 cites
- 3163US7323334B2Screening and therapeutic methods relating to neurogenesisUNIV CALIFORNIA·Filed 2003·Granted Jan 29, 2008·3 cites·9 claims
- 3258US5389543ACloned genes encoding the D1 dopamine receptorUNIV DUKE·Filed 1992·Granted Feb 14, 1995·24 cites·30 claims
- 3354US2005170455A1Novel prokineticin receptor isoforms and methods of useFiled 2004·Application pending·0 cites
- 3453US2005037464A1Prokineticin polypeptides, related compositions and methodsUNIV CALIFORNIA·Filed 2004·Application pending·0 cites
- 3550US10780095B2Compositions and methods for treating disorders of circadian and diurnal rhythms using prokineticin 2 agonists and antagonistsUNIV CALIFORNIA·Filed 2017·Granted Sep 22, 2020·0 cites·9 claims
- 3650US5441883AA3 adenosine receptor, DNA, and usesOREGON STATE·Filed 1993·Granted Aug 15, 1995·13 cites·7 claims
- 3750US2007066530A1Methods for modulating gastric secretion using prokineticin receptor antagonistsZHOU QUN-YONG·Filed 2006·Application pending·0 cites
- 3847US2004235732A1Method for modulating angiogenesis using prokineticin receptor antagonistsFiled 2003·Application pending·0 cites
- 3945US2002115610A1Prokineticin polypeptides, related compositions and methodsFiled 2001·Application pending·0 cites
- 4045US2010286021A1Methods of Modulating Prokineticin 2 for Treatment of Stress Response and Anxiety-Related DisordersZHOU QUN-YONG·Filed 2008·Application pending·0 cites
- 4143US2006141453A9Prokineticin polypeptides, related compositions and methodsZHOU QUN-YONG·Filed 2001·Application pending·0 cites
- 4242US9494666B2NMR measurement of clinically relevant ionized biosample constituents such as ionized calcium and/or magnesiumJEYARAJAH ELIAS·Filed 2007·Granted Nov 15, 2016·2 cites·14 claims
- 4339US2006019338A1Primate prokineticin and prokineticin receptor polypeptides, related compositions and methodsZHOU QUN-YONG·Filed 2005·Application pending·0 cites
- 4435US7598048B2Screening methods for identifying agents that modulate output of a circadian pacemakerUNIV CALIFORNIA·Filed 2003·Granted Oct 6, 2009·0 cites·14 claims
- 4533US2006172935A1Screening and therapeutic methods for treating circadian rhythm disordersZHOU QUN-YONG·Filed 2005·Application pending·0 cites
- 4632US5547845AAqueous solution containing D1 dopamine receptorUNIV DUKE·Filed 1994·Granted Aug 20, 1996·1 cites·8 claims
Join the waitlist — get patent alerts
Get an alert when Qun Zhou files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →